The last sighting

There’s no other way to say it – the FDA strikes again.

In between extorting hundreds of millions of dollars to approve drugs, only to yank many of them off the market a few months later (not to mention placing unconstitutional gag orders on people trying to inform the public of the health benefits of simple vitamin E), they are now making it nearly impossible for you to get your hands on one of nature’s most powerful – and proven – pain relievers.

We first told you about relaxin in the April 2000 Members Alert newsletter. This naturally occurring hormone is best known for its role during pregnancy. Since the 1930s, scientists have known about its key role in softening the tissues of the birth canal, promoting cell proliferation to help the uterus grow, and allowing ligaments and other connective tissues to elongate. Effectively, relaxin transforms the pregnant woman’s body to accommodate its changing needs.
“Pregnancy hormone” relieves FMS symptoms – immediately

After realizing that women typically experience relief from fibromyalgia (FMS) and other pain disorders during pregnancy, scientists hypothesized the relaxin hormone may be responsible, since its production quadruples during pregnancy. To test the theory, they began using it to treat patients suffering from FMS.

Patients treated with relaxin experienced significant relief, some even immediately. Further studies have shown that it offers remarkable benefits in fighting age-related diseases, like osteoporosis, and effectively reduces many of the physical signs of aging, like dry skin and hair – with no side effects. And since the relaxin hormone is present in both sexes, research shows it can help men address pain and aging disorders, as well.
So it must be obvious by now what the FDA is protecting us from – right?

Sky BioHealth Solutions, the manufacturer of the relaxin supplement, Vitalaxin, was so eager to expand the availability of this miracle hormone that it actually chose to take it to the FDA, seeking approval to classify it as a dietary supplement.

Unfortunately, they ran into the typical bureaucratic maze. BioHealth has hit brick wall after brick wall in their bid to make this remarkable product more widely available. In fact, they recently received a letter on official FDA letterhead outright denying their petition.

So despite the fact that this naturally occurring hormone has reportedly brought relief to countless sufferers of chronic and debilitating pain, most distributors have hastily pulled it from their shelves out of fear that overzealous federal agents might swoop in at any moment and close them down.
The last frontier?

Thankfully, Dr. Jonathan Wright, a crusader in the fight to allow people freedom of choice in health care and a long-time friend of HSI, has once again refused to cower in the face of pressure from government bureaucracy. He has made the decision to keep Vitalaxin on the shelves at his Tahoma Clinic Dispensary.

Dr. Wright, a pioneer in the field of nutritional medicine and Medical Director of the Tahoma Clinic, is no stranger to interference by the FDA. In fact, he and his staff once braved a 14-hour ordeal, as armed government officials pawed through confidential patient records, destroyed medical equipment, and ransacked his clinic – simply because he was using preservative-free B vitamins. In the end, no charges were ever filed. But Dr. Wright and his staff were left with a renewed sense of commitment to the fight against the ever-present attempts to restrict people’s health care freedom.

To learn more about the benefits of relaxin for fighting FMS or other chronic pain, you can read the April 2000 article from the HSI Members Alert newsletter. If you are interested in purchasing Vitalaxin from the Tahoma Clinic Dispensary, you can visit their online store at tahoma-clinic.com or call them at (425)264-0059.

And you might want to stock up, there’s no telling when the armed agents might storm down Dr. Wright’s door to confiscate his hormone “stash.”

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:
Oral Porcine Relaxin – 75-Day Premarket Notification
Arch Dermatol 2002 Jan;138(1):99-105
Am J Clin Dermatol 2001;2(5):315-25
BioDrugs 2001;15(9):609-14